Pharma.Global Revenue and Competitors

Abu Dhabi,

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Pharma.Global's estimated annual revenue is currently $7.8M per year.(i)
  • Pharma.Global's estimated revenue per employee is $201,000

Employee Data

  • Pharma.Global has 39 Employees.(i)
  • Pharma.Global grew their employee count by 18% last year.

Pharma.Global's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.2M2305%N/AN/A
#2
$43.8M21821%N/AN/A
#3
$57.1M28426%N/AN/A
#4
$24.5M1223%N/AN/A
#5
$52.9M26313%N/AN/A
#6
$24.7M12313%N/AN/A
#7
$1.8M180%$114.3MN/A
#8
$7.2M36-20%N/AN/A
#9
$13.7M68-7%N/AN/A
#10
$7.6M39-13%$123.9MN/A
Add Company

What Is Pharma.Global?

Pharma.Global is an innovation driven organization with an ecosystem of smart solutions based on Big Data and AI for optimization and growth of the multi-beneficiary global pharma industry. Global mission: to provide affordable and effective pharmaceutical products by supply chain optimization and improved accessibility for global healthcare market and the stakeholders. Vision and Ideology is to support market participants to establish direct communication with each other through removing unnecessary links from the supply chain and raising the effectiveness of the pharma market.

keywords:N/A

N/A

Total Funding

39

Number of Employees

$7.8M

Revenue (est)

18%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Pharma.Global News

2022-04-20 - Leapfrogging into the future of Indian pharma

The Indian pharmaceutical industry ranks third worldwide for production by volume and caters to 20% of the global demand in the generic market...

2022-04-06 - Indian Pharma - Global Health Care honors IDMA's Diamond ...

Indian Pharma - Global Health Care honors IDMA's Diamond Jubilee celebration. ANI | Updated: Apr 06, 2022 15:59 IST. Mumbai (Maharashtra) [India], April 6...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8.5M430%N/A
#2
$7.1M438%N/A
#3
$5.6M484%N/A
#4
$5.6M48N/AN/A
#5
$7.3M56N/AN/A